Currently the Organ Procurement and Transplant Network and CMS use 1-year patient and graft survival as metrics to flag transplant programs.1 Waitlist and longer-term posttransplant outcomes are publicly reported and have been suggested as regulatory metrics, but both involve factors outside the transplant center. We tested how well the current survival metrics capture these other dimensions. We evaluated transplant programs between 2011 and 2016 using hierarchical regression based on 2017 Scientific Registry of Transplant Recipient risk adjustment models.2,3 We used mixed-effect Poisson regression with center and donor service area–level random intercepts for waitlist metrics and center-level shared frailty Cox regression for posttransplant metrics. We ranked centers' risk-adjusted performance from 1 (best) to N (worst) based on center-level random effects from these models and correlated 1-year posttransplant outcomes with 3-year posttransplant outcomes, deceased donor kidney transplant rates, and waitlist mortality. One- and 3-year graft loss were moderately correlated (r = 0.75), as were 1- and 3-year patient mortalities (r = 0.74) (Figure 1). However, 1-year graft loss and mortality correlated poorly with deceased donor kidney transplantation rate (r = 0.02, 0.14), and waitlist mortality (r = −0.23, −0.11) (Figure 1).FIGURE 1: Correlations between rankings of center-level effects (representing average expected outcome at a given center) for adult kidney transplant outcome metrics. One-year posttransplant metrics calculated using adult recipients January 1, 2014, to June 30, 2016 (N = 28847), waitlist metrics include adult waitlist registrants January 1, 2014, to June 30, 2016 (N = 187407), and 3-year metrics include adult recipients July 1, 2011 to December 31, 2013 (N = 26167). Centers that performed less than 25 transplants during the 2.5-year study periods were excluded (N = 190 for 1-year metrics, N = 188 for 3-year metrics). Center-level effects based on mixed-effect Poisson regressions (random intercepts) and Cox regressions (shared-frailty) ranked from 1 (best) to N (worst). This study used data from the SRTR. SRTR, Scientific Registry of Transplant Recipients.The high correlation between 1- and 3-year posttransplant outcomes suggests that regulation based on 1-year metrics is also representative of the longer-term patient experience. In contrast, the independence between posttransplant outcomes versus transplant rates and waitlist outcomes suggests that the underlying mechanisms are different, including the possibility that factors, such as geographic organ availability, affect transplant rates and waitlist outcomes. If these domains are to be regulated, the risk/benefit of using these metrics will require careful evaluation.